Can you take your next Wegovy dose early — and what actually happens if you do?

You glance at the pen in the fridge door and think: it's only been five days, does one day really matter?

It does, and here's why. Semaglutide has a long half-life (roughly seven days) which is precisely why once-weekly dosing works. By the time your next injection is due, your previous dose is winding down to a level that allows the new one to layer in smoothly. Take that second dose two or three days early and the two overlap more heavily than the medicine's pharmacokinetics were designed to accommodate. The result isn't faster weight loss. What tends to happen instead is a sharper rise in plasma concentration, which the gut feels acutely. Nausea that had been settling can return with more force. Vomiting, stomach cramps and fatigue are also more likely. If you're wondering whether increasing your semaglutide dose early is ever appropriate, the short answer is that the dose escalation schedule built into the Wegovy dosing programme is calibrated so your body adapts gradually, and shortcutting it undermines that process.

There's also a subtler point. If your injection days drift earlier each week, by month three you could be on a de facto six-day cycle, which compounds the overlap problem over time. Consistency on a fixed day (same morning, same routine) makes the schedule easier to hold and the side-effect profile more predictable.

What the licensed guidance actually says about missed and misaligned doses

The Patient Information Leaflet, which reflects the approved Wegovy SmPC, gives clear missed-dose guidance: if fewer than five days have passed since your scheduled injection day, take the missed dose as soon as you remember, then return to your usual day. If five or more days have passed, skip the missed dose entirely and wait for your next scheduled injection. What it doesn't allow is taking a dose ahead of schedule because you feel ready for it, or because you've seen that moving to a higher strength sooner might accelerate results. The NHS medicines guidance for semaglutide echoes this: your prescriber or pharmacist is the right first call when something with your schedule goes wrong, not a forum, not a best guess.

If you're finding the current dose isn't doing much and you're curious about the titration process, that's a legitimate clinical conversation. A prescriber who understands what comes next in the Wegovy sequence can advise whether you're ready for a step up at your next scheduled review, but that decision belongs in a consultation, not in your kitchen on a Tuesday evening.

Changing your injection day on purpose, when it's actually fine

There is one scenario where moving your injection day is entirely appropriate: a deliberate, planned shift agreed with your prescriber. People do this for practical reasons, travel, a recurring work commitment, fitting the injection around an event. The approach is simple in principle: on the week you want to make the switch, take your dose on the new day, making sure the gap from your previous injection is at least two days. From that point forward, the new day becomes your fixed schedule. It's a one-off adjustment, not a rolling shortcut. The minimum two-day gap is the floor, not the target, the closer you can keep it to seven days, the better tolerated the change will be. If you're managing this kind of shift and want a clinical eye on it, our patient support team is available seven days a week.

For anyone thinking about longer-term changes to their Wegovy journey (including switching formulations or moving onto Wegovy for maintenance) those conversations are always worth having with a prescriber rather than navigating alone. The weekly schedule is one of those things that sounds simple until you're in the middle of it.

The broader picture: why the schedule matters as much as the medicine

Wegovy is a prescription-only medicine, which means the structure around it (timing, dose increases, monitoring) carries the same weight as the prescription itself. Clinical trials like STEP 1, published in the New England Journal of Medicine, achieved around 15% average weight reduction over 68 weeks precisely because participants followed the titrated, weekly protocol under clinical oversight. The results aren't detachable from the method. Taking doses early, inconsistently, or without clinical review doesn't accelerate the outcome, it increases the risk of side effects that can themselves disrupt adherence.

If you're considering whether Wegovy suits your situation at all, or you want to explore your options with a prescriber who reviews cases the same day, our free consultation is the right starting point. A real clinician reads your answers (not software) and the process from there is straightforward. You can also read more about how Wegovy works and the broader range of weight-loss treatment options we support. For context on what private treatment typically involves, our FAQs cover the most common practical questions.